Similarly, in a study by Peltola et al. [13] involving 71 patients with HNSCC treated with surgery and/or radiotherapy, those patients with elevated immunohistochemical expression of PIM-1 tended to have poorer survival (P = 0.09). This evidence concerns the gene PIM1 and head and neck squamous cell carcinoma.